시장보고서

상품코드

1575037

기능적 서비스 프로바이더(FSP) 시장 : 유형별, 질병 유형별, 최종사용자별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2024-2032년)

Functional Service Providers (FSP) Market, By Type, By Disease Type, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

발행일: 2024년 10월 | 리서치사:

AnalystView Market Insights | 페이지 정보: 영문 284 Pages | 배송안내 : 2-3일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

보고서 하이라이트

기능적 서비스 프로바이더(FSP) 시장 규모는 2023년 147억 3,043만 달러로 2024년부터 2032년까지 CAGR 8.30%로 확대될 것으로 예상됩니다.

기능적 서비스 프로바이더(FSP) 시장 - 시장 역학

임상시험 및 헬스케어 분야의 아웃소싱 수요 증가가 시장 수요를 촉진할 것으로 예상

헬스케어 기업들은 핵심 비즈니스 목표에 집중하고 운영 비용을 절감하며 효율성을 높이기 위해 비 핵심 기능을 FSP에 아웃소싱하는 경향이 증가하고 있습니다. 임상시험이 더욱 복잡해지고 세계화됨에 따라 FSP는 규제 요건과 물류 문제를 해결할 수 있는 전문 지식과 리소스를 제공하고 있습니다. 또한 인공지능, 빅데이터 분석, 디지털 헬스 솔루션과 같은 첨단 기술의 통합은 FSP의 역량을 강화하고 고객에게 더욱 매력적인 서비스를 제공하고 있습니다.

FSP는 또한 전문 지식, 확립된 프로세스 및 기술을 활용하여 비용 효율적인 솔루션을 제공함으로써 고객 조직이 운영 비용을 절감할 수 있도록 돕습니다. 환자 중심 치료 모델과 맞춤형 의료로의 전환은 맞춤형 임상 개발 및 환자 참여 전략을 지원할 수 있는 FSP의 채택을 촉진하고 있습니다. 또한, 제약 및 생명공학 기업의 R&D 투자 확대는 의약품 개발을 촉진하고 새로운 치료법을 시장에 출시하기 위해 FSP 서비스에 대한 수요를 촉진하고 있습니다.

기능적 서비스 프로바이더 시장 - 주요 인사이트

리서치 애널리스트의 분석에 따르면, 세계 시장은 예측 기간(2024-2032년) 동안 매년 약 8.30%의 CAGR로 성장할 것으로 예상됩니다.

유형별로는 임상시험에서 FSP에 대한 높은 수요로 인해 임상시험 설계 및 모니터링 부문이 2023년 가장 큰 시장 점유율을 차지할 것으로 예측됐습니다.

질병 유형별로는 2023년 주요 질병 유형은 종양학 분야로, 제약회사와 생명공학 기업 간의 제휴가 증가함에 따라 종양학 분야가 가장 큰 비중을 차지했습니다.

최종사용자별로는 연구비 지출과 기능적 서비스 이용이 증가함에 따라 바이오 제약회사가 2023년 주요 최종사용자로 꼽혔습니다.

지역별로는 북미가 2023년 주요 수익원이 되었는데, 이는 의료 산업에서 첨단 기술이 존재하기 때문으로 분석됩니다.

기능적 서비스 프로바이더(FSP) 시장 - 세분화 분석:

세계 기능적 서비스 프로바이더(FSP) 시장은 유형, 질병 유형, 최종사용자 및 지역을 기준으로 세분화됩니다.

유형별로는 임상시험 설계 및 모니터링, 데이터 관리, 약물감시, 약물감시, 메디컬 라이팅, 기타 5가지로 나뉩니다. 임상시험 설계 및 모니터링 분야가 시장을 주도하고 있습니다. 실시간 관리의 기술 도입과 모니터링의 이점이 시장 성장을 견인하고 있습니다.

질병 유형에 따라 시장은 암, 감염성 질환, 심혈관질환, 신경 질환, 면역학, 기타 6가지로 나뉩니다. 종양학 분야가 시장을 주도하고 있으며, CRO와 바이오 제약사들이 비뇨기과와 혈액 질환에 대한 전문성을 확보하기 위해 연구에 투자하고 있어 이 분야의 수요가 증가하고 있습니다.

시장은 최종사용자에 따라 바이오 제약사, CRO, 기타 세 가지로 분류됩니다. 바이오 제약사가 시장을 독점하고 있으며, 예측 기간 동안 높은 우위를 유지할 것으로 보입니다. 스폰서와 FSP의 협업 전략이 활발해지면서 임상 개발에 대한 통합적 접근이 증가하고 있습니다.

기능적 서비스 프로바이더(FSP) 시장 - 지리적 인사이트

지역적으로는 북미, 라틴아메리카, 유럽, 아시아태평양, 중동 및 아프리카에 분포되어 있습니다. 북미, 특히 미국은 제약회사와 바이오테크 기업이 집중되어 있고, 임상연구와 의약품 개발에 많은 투자를 하고 있어 FSP 서비스의 최대 시장입니다. 유럽 역시 임상연구에 대한 정부의 강력한 지원, 많은 바이오테크 기업, 복잡한 규제 환경으로 인해 FSP 서비스의 주요 시장으로 성장하고 있습니다. 아시아태평양은 임상시험의 증가와 운영 비용의 감소로 인해 FSP 시장이 빠르게 성장하고 있습니다.

기능적 서비스 프로바이더(FSP) 시장 - 경쟁 상황:

기능적 서비스 프로바이더(FSP) 시장은 경쟁이 치열하며, 제약, 생명공학, 임상 연구 기관에 전문 서비스를 제공하는 다양한 기업이 존재합니다. 각 업체들은 FSP 서비스를 강화하기 위해 기술에 많은 투자를 하고 있습니다. 인공지능, 빅데이터 분석, 클라우드 기반 플랫폼을 활용하여 임상시험 운영, 데이터 관리, 환자 모집을 최적화하고, 아시아태평양(중국, 인도), 라틴아메리카, 동유럽 등 신흥 시장에서의 임상 연구 활동 확대에 대응하기 위해 FSP 제공업체들이 지리적 발자국을 넓히고 있습니다. 지리적 입지를 확장하고 있습니다. 이러한 확장은 보다 광범위한 환자 풀에 대한 접근과 비용 효율적인 솔루션을 제공할 수 있게 해줍니다.

2023년 1월, Premier Research와 Centogene N.V.는 임상시험의 엔드 투 엔드 지원을 제공하기 위해 제휴했습니다.

2022년 12월, 생물통계학 분야에서 높은 경험을 가진 에베레스트 임상연구(Everest Clinical Research)가 사업 확장을 위해 브라이트텍 인터내셔널(Brightech International)을 인수했습니다.

소개
북미
- 개요
- 북미의 주요 제조업체
- 미국
- 캐나다
유럽
- 개요
- 유럽의 주요 제조업체
- 독일
- 이탈리아
- 영국
- 프랑스
- 러시아
- 네덜란드
- 스웨덴
- 폴란드
- 기타
아시아태평양(APAC)
- 개요
- 아시아태평양의 주요 제조업체
- 인도
- 중국
- 일본
- 한국
- 호주
- 태국
- 인도네시아
- 필리핀
- 기타
라틴아메리카
- 개요
- 라틴아메리카의 주요 제조업체
- 브라질
- 멕시코
- 아르헨티나
- 콜롬비아
- 기타
중동 및 아프리카
- 개요
- 중동 및 아프리카의 주요 제조업체
- 사우디아라비아
- 아랍에미리트
- 이스라엘
- 터키
- 알제리
- 이집트
- 기타

제11장 주요 벤더 분석 - 기능적 서비스 프로바이더(FSP) 업계

경쟁 대시보드
기업 개요
- IQVIA
- Labcorp Drug Development
- Parexel
- ICON plc
- Everest Clinical Research
- Thermo Fisher Scientific
- Syneos Health
- Medpace
- Charles River Laboratories
- KCR
- Worldwide Clinical Trials
- Veristat
- Celerion
- Pharm-Olam
- Premier Research
- Others

제12장 애널리스트의 전방위 전망

ksm 24.11.06

REPORT HIGHLIGHT

Functional Service Providers (FSP) Market size was valued at USD 14,730.43 Million in 2023, expanding at a CAGR of 8.30% from 2024 to 2032.

A Functional Service Provider (FSP) is a type of outsourcing model commonly used in the pharmaceutical and clinical research industries. Under this model, companies like pharmaceutical firms, biotechnology companies, and clinical research organizations (CROs) outsource specific functions or activities to a third-party service provider.

Functional Service Providers (FSP) Market- Market Dynamics

Rising demand for outsourcing in clinical trials and healthcare sector is expected to propel market demand

Healthcare companies are increasingly outsourcing non-core functions to FSPs to focus on their primary business objectives, reduce operational costs, and enhance efficiency. As clinical trials become more complex and globalized, FSPs offer expertise and resources that help navigate regulatory requirements and logistical challenges. Also, the integration of advanced technologies, such as artificial intelligence, big data analytics, and digital health solutions, enhances the capabilities of FSPs, making their services more attractive to clients.

FSPs also provide cost-effective solutions by leveraging their expertise, established processes, and technologies, allowing client organizations to save on operational costs. The shift toward patient-centric care models and personalized medicine encourages the adoption of FSPs that can support tailored clinical development and patient engagement strategies. In addition, growing investments in research and development by pharmaceutical and biotech companies drive the demand for FSP services to facilitate drug development and bring new therapies to market.

Functional Service Providers (FSP) Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.30% over the forecast period (2024-2032)

Based on Type segmentation, the clinical trial design & monitoring segment was predicted to show maximum market share in the year 2023, owing to high demand for FSP from clinical trials.

Based on Disease Type segmentation, oncology segment was the leading Disease Type segment in 2023, due to the rising partnerships between pharma & biotech companies.

Based on End User segmentation, biopharmaceutical companies segment was the leading End User segment in 2023, due to the increasing research spending & use of functional services.

On the basis of region, North America was the leading revenue generator in 2023, due to the presence of advanced tech in the medical industry.

Functional Service Providers (FSP) Market- Segmentation Analysis:

Global Functional Service Providers (FSP) Market is segmented on the basis of Type, Disease Type, End User, and Region.

The market is divided into five categories based on Type: clinical trial design & monitoring, data management, pharmacovigilance, medical writing, and others. The clinical trial design & monitoring segment dominates the market. Technology adoption & monitoring benefits in real time management is supporting market growth.

The market is divided into six categories based on Disease Type: oncology, infectious diseases, cardiovascular diseases, neurological diseases, immunology, and others. The oncology segment dominates the market. CROs and biopharma companies investing in research to expertise in urology, hematology disorders which is boosting segment demand.

The market is divided into three categories based on End User: biopharmaceutical companies, CROs, and others. The biopharmaceutical companies segment dominates the market and is expected to maintain its high dominance during the forecast period. Increasing collaborative strategy between sponsors and FSPs is raising integrated approach to clinical development.

Functional Service Providers (FSP) Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America, especially the United States, is the largest market for FSP services due to the high concentration of pharmaceutical and biotechnology companies, as well as significant investments in clinical research and drug development. Europe is another prominent market for FSP services, driven by strong government support for clinical research, many biotechnology firms, and a complex regulatory environment. The Asia-Pacific region is experiencing rapid growth in the FSP market, fueled by the increasing number of clinical trials, lower operational costs.

Functional Service Providers (FSP) Market- Competitive Landscape:

The Functional Service Provider (FSP) market is highly competitive, with a diverse set of companies offering specialized services to pharmaceutical, biotechnology, and clinical research organizations. Companies are investing heavily in technology to enhance their FSP offerings. This includes leveraging artificial intelligence, big data analytics, and cloud-based platforms to optimize clinical trial operations, data management, and patient recruitment. FSP providers are expanding their geographic footprint to tap into the growing clinical research activity in emerging markets such as Asia-Pacific (China, India), Latin America, and Eastern Europe. This expansion enables access to a broader patient pool and cost-effective solutions.

In January 2023, Premier Research and Centogene N.V. collaborated to offer end-to-end support in clinical trials.

In December 2022, Everest Clinical Research with high experience in biostatistics acquired Brightech International to expand their business.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL FUNCTIONAL SERVICE PROVIDERS (FSP) MARKET KEY PLAYERS

IQVIA
Labcorp Drug Development
Parexel
ICON plc
Everest Clinical Research
Thermo Fisher Scientific
Syneos Health
Medpace
Charles River Laboratories
KCR
Worldwide Clinical Trials
Veristat
Celerion
Pharm-Olam
Premier Research
Others

GLOBAL FUNCTIONAL SERVICE PROVIDERS (FSP) MARKET, BY TYPE- MARKET ANALYSIS, 2019-2032

Clinical trial design & monitoring
Data management
Pharmacovigilance
Medical writing
Others

GLOBAL FUNCTIONAL SERVICE PROVIDERS (FSP) MARKET, BY DISEASE TYPE- MARKET ANALYSIS, 2019-2032

Oncology
Infectious diseases
Cardiovascular diseases
Neurological diseases
Immunology
Others

GLOBAL FUNCTIONAL SERVICE PROVIDERS (FSP) MARKET, BY END USER- MARKET ANALYSIS, 2019-2032

Biopharmaceutical Companies
CROs
Others

GLOBAL FUNCTIONAL SERVICE PROVIDERS (FSP) MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

1. Functional Service Providers (FSP) Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Functional Service Providers (FSP) Market Snippet by Type
- 2.1.2. Functional Service Providers (FSP) Market Snippet by Disease Type
- 2.1.3. Functional Service Providers (FSP) Market Snippet by End User
- 2.1.4. Functional Service Providers (FSP) Market Snippet by Country
- 2.1.5. Functional Service Providers (FSP) Market Snippet by Region
2.2. Competitive Insights

3. Functional Service Providers (FSP) Key Market Trends

3.1. Functional Service Providers (FSP) Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Functional Service Providers (FSP) Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Functional Service Providers (FSP) Market Opportunities
3.4. Functional Service Providers (FSP) Market Future Trends

4. Functional Service Providers (FSP) Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Functional Service Providers (FSP) Market: COVID-19 Impact Analysis

5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments

6. Functional Service Providers (FSP) Market Landscape

6.1. Functional Service Providers (FSP) Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Functional Service Providers (FSP) Market - By Type

7.1. Overview
- 7.1.1. Segment Share Analysis, By Type, 2024 & 2032 (%)
- 7.1.2. Clinical trial design & monitoring
- 7.1.3. Data management
- 7.1.4. Pharmacovigilance
- 7.1.5. Medical writing
- 7.1.6. Others

8. Functional Service Providers (FSP) Market - By Disease Type

8.1. Overview
- 8.1.1. Segment Share Analysis, By Disease Type, 2024 & 2032 (%)
- 8.1.2. Oncology
- 8.1.3. Infectious diseases
- 8.1.4. Cardiovascular diseases
- 8.1.5. Neurological diseases
- 8.1.6. Immunology
- 8.1.7. Others

9. Functional Service Providers (FSP) Market - By End User

9.1. Overview
- 9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
- 9.1.2. Biopharmaceutical Companies
- 9.1.3. CROs
- 9.1.4. Others

10. Functional Service Providers (FSP) Market- By Geography

10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
10.2. North America
- 10.2.1. Overview
- 10.2.2. Functional Service Providers (FSP) Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.2.7. U.S.
  - 10.2.7.1. Overview
  - 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.7.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.2.7.4. U.S. Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.2.8. Canada
  - 10.2.8.1. Overview
  - 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.8.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.2.8.4. Canada Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3. Europe
- 10.3.1. Overview
- 10.3.2. Functional Service Providers (FSP) Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.7. Germany
  - 10.3.7.1. Overview
  - 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.7.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.3.7.4. Germany Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.8. Italy
  - 10.3.8.1. Overview
  - 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.8.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.3.8.4. Italy Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.3.8.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.9. United Kingdom
  - 10.3.9.1. Overview
  - 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.9.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.3.9.4. United Kingdom Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.10. France
  - 10.3.10.1. Overview
  - 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.10.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.3.10.4. France Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.3.10.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.11. Russia
  - 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.11.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.3.11.3. Russia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.3.11.4. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.12. Netherlands
  - 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.12.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.3.12.3. Netherlands Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.13. Sweden
  - 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.13.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.3.13.3. Sweden Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.3.13.4. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.14. Poland
  - 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.14.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.3.14.3. Poland Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.3.14.4. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.15. Rest of Europe
  - 10.3.15.1. Overview
  - 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.3.15.4. Rest of the Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. Functional Service Providers (FSP) Key Manufacturers in Asia Pacific
- 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.4.5. Asia Pacific Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.7. India
  - 10.4.7.1. Overview
  - 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.7.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.4.7.4. India Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.4.7.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.8. China
  - 10.4.8.1. Overview
  - 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.8.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.4.8.4. China Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.9. Japan
  - 10.4.9.1. Overview
  - 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.9.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.4.9.4. Japan Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.10. South Korea
  - 10.4.10.1. Overview
  - 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.10.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.4.10.4. South Korea Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.11. Australia
  - 10.4.11.1. Overview
  - 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.11.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.4.11.4. Australia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.12. Thailand
  - 10.4.12.1. Overview
  - 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.12.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.4.12.4. Thailand Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.4.12.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.13. Indonesia
  - 10.4.13.1. Overview
  - 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.13.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.4.13.4. Indonesia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.14. Philippines
  - 10.4.14.1. Overview
  - 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.14.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.4.14.4. Philippines Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.15. Rest of APAC
  - 10.4.15.1. Overview
  - 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.4.15.4. Rest of APAC Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.5. Latin America
- 10.5.1. Overview
- 10.5.2. Functional Service Providers (FSP) Key Manufacturers in Latin America
- 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.5.5. Latin America Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 10.5.6. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.5.7. Brazil
  - 10.5.7.1. Overview
  - 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.7.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.5.7.4. Brazil Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.5.8. Mexico
  - 10.5.8.1. Overview
  - 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.8.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.5.8.4. Mexico Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.5.9. Argentina
  - 10.5.9.1. Overview
  - 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.9.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.5.9.4. Argentina Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.5.10. Colombia
  - 10.5.10.1. Overview
  - 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.10.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.5.10.4. Colombia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.5.11. Rest of LATAM
  - 10.5.11.1. Overview
  - 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.5.11.4. Rest of LATAM Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6. Middle East and Africa
- 10.6.1. Overview
- 10.6.2. Functional Service Providers (FSP) Key Manufacturers in Middle East and Africa
- 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.6.5. Middle East and Africa Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.7. Saudi Arabia
  - 10.6.7.1. Overview
  - 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.6.7.4. Saudi Arabia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.8. United Arab Emirates
  - 10.6.8.1. Overview
  - 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.8.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.6.8.4. United Arab Emirates Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.9. Israel
  - 10.6.9.1. Overview
  - 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.9.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.6.9.4. Israel Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.10. Turkey
  - 10.6.10.1. Overview
  - 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.10.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.6.10.4. Turkey Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.11. Algeria
  - 10.6.11.1. Overview
  - 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.11.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.6.11.4. Algeria Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.12. Egypt
  - 10.6.12.1. Overview
  - 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.12.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.6.12.4. Egypt Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.13. Rest of MEA
  - 10.6.13.1. Overview
  - 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.6.13.4. Rest of MEA Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Functional Service Providers (FSP) Industry

11.1. Competitive Dashboard
11.2. Company Profiles
- 11.2.1. IQVIA
- 11.2.2. Labcorp Drug Development
- 11.2.3. Parexel
- 11.2.4. ICON plc
- 11.2.5. Everest Clinical Research
- 11.2.6. Thermo Fisher Scientific
- 11.2.7. Syneos Health
- 11.2.8. Medpace
- 11.2.9. Charles River Laboratories
- 11.2.10. KCR
- 11.2.11. Worldwide Clinical Trials
- 11.2.12. Veristat
- 11.2.13. Celerion
- 11.2.14. Pharm-Olam
- 11.2.15. Premier Research
- 11.2.16. Others

12. 360 Degree Analyst View

13. Appendix

13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us